References
- Andrén-Sandberg Å., Isacson S. Tissue polypeptide antigen in colorectal carcinoma. Clinical application of carcinoembryonic antigen assay, B. P. Krebs, C. M. Lalanne, M. Schneider. Excerpta Medica, Amsterdam 1978; 139
- Björklund B. On the nature and clinical use of tissue polypeptide antigen (TPA). Tumor Diagnostik 1980; 1: 9
- Elandt-Johnson R. C., Johnson N. L. Survival models and data analysis. John Wiley and Sons, New York, Chichester, Brisbane, Toronto 1980
- Gehrke C. W., Kuo K. C., Waalkes T. P., Borek E. Patterns of urinary excretion of modified nucleosides. Cancer Res. 1979; 39: 1150
- Gehrke C. W., Kuo K. C., Davis G. E., Suits R. D., Waalkes T. P., Borek E. Quantitative high-performance liquid chromatography of nucleosides in biological materials. J. Chromatogr. 1978; 150: 455
- Haagensen D. E., Easterday R. L., Stolle C. A., Wells S. A. Buffer-exchange column for rapid separation of carcinoembryonic antigen from perchloric acid. Clin. Chem. 1978; 24: 135
- Hansen H. J., Snyder J. J., Miller E., et al. Carcinoembryonic antigen (CEA) assay, a laboratory adjunct in the diagnosis and management of cancer. Human Pathol. 1974; 5: 139
- Higley B., De Mello J., Oakes D. J., Giles G. R. Urinary pseudouridine/creatinine ratio as an indicator of gastrointestinal cancer. Brit. J. Surg. 1982; 69: 699
- Holyoke E. D., Chu T. M., Murphy G. P. CEA as a monitor of gastrointestinal malignancy. Cancer 1975; 35: 830
- Kuo K. C., Gehrke C. W., McCune R. A., Waalkes T. P., Borek E. Rapid, quantitative high-performance liquid column chromatography of pseudouridine. J. Chromatogr. 1978; 145: 383
- Menendez-Botet C. J., Oettgen H. F., Pinsky C. M., Schwartz M. K. A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasms. Clin. Chem. 1978; 24: 868
- Nathanson L., Fishman W. H. New observations on the Regan isoenzyme of alkaline phosphatase in cancer patients. Cancer 1971; 27: 1388
- Rasmuson T., Björk G. R., Damber L., . Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase, and modified nucleosides as biological markers in malignant lymphomas. Recent results in cancer research, G. Nass, et al. Springer Verlag, Berlin, Heidelberg, New York 1983; Vol. 84: 331
- Rasmuson T., Björk G. R., Damber L., et al. Tumor markers in bronchogenic carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine. Acta radiol. Oncology 1983; 22: 209
- Speer J., Gehrke C. W., Kuo K. C., Waalkes T. P., Borek E. tRNA breakdown products as markers for cancer. Cancer 1979; 44: 2120
- Stigbrand T., Holmgren P. Ä., Jeppsson A., Damber M.-G., von Schoultz B. On the value of placental alkaline phosphatase as a marker for gynaecological malignancy. Acta Obstet. Gynecol. Scand. 1983, in press
- Usategui-Gomez M., Yeager F. M., Fernandez de Castro A. A sensitive immunochemical method for the determination of the Regan isoenzyme in serum. Cancer Res. 1973; 33: 1574
- Waalkes T. P., Gehrke C. W., Zumwalt R. W., et al. The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer. Cancer 1975; 36: 390
- Wanebo H. J., Rao B., Pinsky C. M., et al. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. New Engl. J. Med. 1978; 299: 448
- Wiklund B., Kallin E., Andersson K., Björklund B. Radioimmunoassay of tissue polypeptide antigen versus hemagglutination technique. Protides of the biological fluids, H. Peeters. Pergamon Press, Oxford 1979; 243